Sun Pharma Advanced Research Company Ltd

₹208.75▲ +2.96%29 Sept

📊 Stock Analysis

Market Data

Market Cap₹6,774.39 Cr.

52W High₹289

Current Price₹208.75

52W Low₹108.2

Down from 52W High27.8 %

Face Value₹1

Performance

ROCE85.5 %

ROE118.33 %

EPS (TTM)₹-0.64

EPS Prev Qtr₹54.27

EPS Last Year₹-2.34

EBITDA Qtr₹-36.2 Cr.

Book Value₹41

Financial Health

Debt/Equity0.42

Debt/Profit0.35

Total Assets₹2,170.876 Cr.

Promoter Holding65.67 %

Earning Power74.03 %

Valuation

Stock P/E4.28

Industry P/E33.3

Price to Book5.06

Price to Sales3.55

Graham Number₹212.85

Key Metrics

Face Value

₹1

About Sun Pharma Advanced Research Company Ltd

Healthcare · Pharmaceuticals

Sun Pharma Advanced Research Company Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹1. Market cap ₹6,774.39 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.9	₹4,46,276.3 Cr	0.86%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	85.97	₹2,51,531.48 Cr	0.32%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	78.4	₹1,86,956.51 Cr	0.77%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	26.64	₹1,19,221.66 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.13	₹1,11,725.01 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	98.01	₹1,07,271.96 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Mankind Pharma Ltd	-	51.42	₹1,05,107.48 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Dr Reddys Laboratories Ltd	-	32.31	₹1,04,334.48 Cr	0.64%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Aurobindo Pharma Ltd	-	26.61	₹97,986.86 Cr	0.23%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.63	₹94,189.9 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	37.59	₹67,587.09 Cr	0.1%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	29.02	₹62,609.02 Cr	1.01%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	111.18	₹61,602.44 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.88	₹57,939.73 Cr	1.74%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Gland Pharma Ltd	-	43.62	₹49,299.85 Cr	0.67%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ipca Laboratories Ltd	-	36.55	₹49,280.78 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	85	₹49,084.9 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Glaxosmithkline Pharmaceuticals Ltd	-	44.95	₹47,217.7 Cr	2.05%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ajanta Pharma Ltd	-	39.17	₹44,452.1 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	7.86	8.45	1,853.22	39.92
↳ QoQ Growth	-	+7.5%	+21831.6%	-97.8%
Expenses	76.14	67.66	82.42	76.12
Operating Profit	-68.28	-59.21	1,770.8	-36.2
OPM %	-868.7%	-700.71%	95.55%	-90.68%
Other Income	0.01	0	1.8	23.66
Interest	7.52	8.78	11.64	8.13
Depreciation	2.56	2.57	2.4	2.2
EBITDA	-65.72	-56.64	1,773.2	-34
EBITDA Margin %	-836.13%	-670.3%	95.68%	-85.17%
Profit Before Tax	-75.79	-80.35	1,760.96	-20.67
Tax %	-0.08%	-0.09%	-0.02%	-0.53%
Net Profit	-75.85	-80.42	1,761.34	-20.78
↳ QoQ Growth	-	-6.0%	+2290.2%	-101.2%
EPS	-2.34	-2.48	54.27	-0.64

Balance Sheet

	Mar 2024	Mar 2025	Mar 2026
Equity Capital	32.45	32.45	32.453
Reserves	93.3	-249.4	1306.3741
Borrowings	61.15	268.92	556.14
Other Liabilities	328.14	283.56	275.91
Total Liabilities	515.04	335.53	2170.8762
Fixed Assets	107.35	98.7	156.5324
CWIP	1.26	0.56	0.4972
Investments	1.8	0	0
Other Assets	404.63	236.27	2013.85
Total Assets	515.04	335.53	2170.8762